P1-060a Phase II Study of Nab-PTX in Combination With RAM in Patients With Pre-Treated AGC: Results of Final Analysis

Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdy375.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

VXM01 Phase I Study in Patients With Progressive Glioblastoma: Final Results.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2018English

Phase I Study of CC-486 Alone and in Combination With Carboplatin or Nab‑paclitaxel in Patients With Relapsed or Refractory Solid Tumors

Clinical Cancer Research
Cancer ResearchOncology
2018English

The Prospects for Cisplatin and Nab-Paclitaxel Combination Therapy in Patients With Pre-Treated Triple-Negative Breast Cancer. Description of the Clinical Case.

Medical Council
2018English

Brentuximab Vedotin Followed by ABVD +/− Radiotherapy in Patients With Previously Untreated Hodgkin Lymphoma: Final Results of a Pilot Phase II Study

Haematologica
Hematology
2015English

Carboplatin in Combination With Epirubicin and Cyclophosphamide in Patients With Advanced Ovarian Cancer: A Phase II Study

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1995English

A Multi-Center, Phase II Trial of Nab-Paclitaxel and Gemcitabine in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

Cancer Management and Research
Oncology
2019English

P3.01-105 Retrospective Analysis of Efficacy and Safety in Chinese Elderly Patients Treated With Nab-Paclitaxel

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Gemcitabine Plus Carboplatin in Patients With Advanced Hepatocellular Carcinoma: Results of a Phase II Study

ISRN Oncology
2012English

A Phase II Trial of Erlotinib in Combination With Bevacizumab in Patients With Metastatic Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy